Annual ROE
45.04%
-11.95%-20.97%
December 31, 2023
Summary
- As of February 7, 2025, GRTX annual return on equity is 45.04%, with the most recent change of -11.95% (-20.97%) on December 31, 2023.
- During the last 3 years, GRTX annual ROE has risen by +1258.15% (+103.71%).
- GRTX annual ROE is now -67.56% below its all-time high of 138.84%, reached on December 31, 2021.
Performance
GRTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
14.34%
-7.61%-34.67%
September 1, 2024
Summary
- As of February 7, 2025, GRTX quarterly return on equity is 14.34%, with the most recent change of -7.61% (-34.67%) on September 1, 2024.
- Over the past year, GRTX quarterly ROE has dropped by -35.91% (-71.46%).
- GRTX quarterly ROE is now -99.76% below its all-time high of 5931.02%, reached on June 30, 2021.
Performance
GRTX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
GRTX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.0% | -71.5% |
| 3 y3 years | +103.7% | -71.5% |
| 5 y5 years | +99.4% | -71.5% |
GRTX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -67.6% | at low | -93.9% | at low |
| 5 y | 5-year | -67.6% | +103.7% | -99.8% | +101.0% |
| alltime | all time | -67.6% | +103.7% | -99.8% | +101.0% |
Galera Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 14.34%(-34.7%) |
| Jun 2024 | - | 21.95%(-39.1%) |
| Mar 2024 | - | 36.07%(-28.2%) |
| Dec 2023 | 45.04%(-21.0%) | 50.25%(-19.2%) |
| Sep 2023 | - | 62.17%(-7.7%) |
| Jun 2023 | - | 67.39%(+1.2%) |
| Mar 2023 | - | 66.56%(-3.6%) |
| Dec 2022 | 56.99%(-59.0%) | 69.06%(-15.0%) |
| Sep 2022 | - | 81.29%(-25.4%) |
| Jun 2022 | - | 108.96%(-30.5%) |
| Mar 2022 | - | 156.75%(-33.2%) |
| Dec 2021 | 138.84% | 234.69%(-48.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | 458.27%(-92.3%) |
| Jun 2021 | - | 5931.02%(-1303.4%) |
| Mar 2021 | - | -492.86%(+106.0%) |
| Dec 2020 | -1213.11%(+1526.2%) | -239.20%(+58.4%) |
| Sep 2020 | - | -151.01%(-89.7%) |
| Jun 2020 | - | -1467.96%(+12.3%) |
| Mar 2020 | - | -1306.93%(-391.1%) |
| Dec 2019 | -74.60%(-430.2%) | 449.03%(+614.3%) |
| Sep 2019 | - | 62.86%(-43.2%) |
| Jun 2019 | - | 110.75%(+380.5%) |
| Mar 2019 | - | 23.05%(+74.9%) |
| Dec 2018 | 22.59%(-27.0%) | 13.18% |
| Dec 2017 | 30.94% | - |
FAQ
- What is Galera Therapeutics annual return on equity?
- What is the all time high annual ROE for Galera Therapeutics?
- What is Galera Therapeutics annual ROE year-on-year change?
- What is Galera Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Galera Therapeutics?
- What is Galera Therapeutics quarterly ROE year-on-year change?
What is Galera Therapeutics annual return on equity?
The current annual ROE of GRTX is 45.04%
What is the all time high annual ROE for Galera Therapeutics?
Galera Therapeutics all-time high annual return on equity is 138.84%
What is Galera Therapeutics annual ROE year-on-year change?
Over the past year, GRTX annual return on equity has changed by -11.95% (-20.97%)
What is Galera Therapeutics quarterly return on equity?
The current quarterly ROE of GRTX is 14.34%
What is the all time high quarterly ROE for Galera Therapeutics?
Galera Therapeutics all-time high quarterly return on equity is 5931.02%
What is Galera Therapeutics quarterly ROE year-on-year change?
Over the past year, GRTX quarterly return on equity has changed by -35.91% (-71.46%)